Biodesix, Inc. (BDSX)
15.18
+0.81
(+5.64%)
USD |
NASDAQ |
May 21, 16:00
15.30
+0.12
(+0.79%)
After-Hours: 19:59
Biodesix Cash from Investing (Quarterly) : -0.144M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Interpace Biosciences, Inc. | -0.141M |
| GRAIL, Inc. | -93.44M |
| FONAR Corp. | -0.173M |
| Thermo Fisher Scientific, Inc. | -8.961B |
| Innovative MedTech, Inc. | -0.1275M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.17M |
| Cash from Financing (Quarterly) | 16.90M |
| Free Cash Flow | -25.27M |
| Free Cash Flow Per Share (Quarterly) | -1.068 |
| Free Cash Flow to Equity (Quarterly) | -9.068M |
| Free Cash Flow to Firm (Quarterly) | -8.335M |
| Free Cash Flow Yield | -20.45% |